Diabetes Drug Linked to Exceptional Longevity in Women
Baca dalam 60 detik
- Researchers analyzed data from thousands of women, finding that metformin users had a significantly lower mortality risk compared to non-users.
- The drug's impact on longevity was most pronounced in those who started treatment early.
- These results suggest metformin may influence aging pathways beyond glucose control.
Researchers analyzed data from thousands of women, finding that metformin users had a significantly lower mortality risk compared to non-users. The drug's impact on longevity was most pronounced in those who started treatment early. These results suggest metformin may influence aging pathways beyond glucose control.
Metformin works by activating AMPK, a cellular energy sensor that mimics the effects of calorie restriction. This mechanism may reduce inflammation and oxidative stress, key drivers of aging. The study adds to growing evidence that repurposing existing drugs could unlock anti-aging therapies.
While promising, experts caution that metformin is not a universal longevity pill. The benefits observed in women may not translate to men or younger populations. Further clinical trials are needed to confirm causal effects and optimal dosing strategies.
Power Move: Metformin's potential as an anti-aging agent could reshape preventive medicine. If validated, this cheap, generic drug might become a cornerstone of longevity protocols, forcing a shift from reactive treatment to proactive lifespan extension.
This article was edited with AI assistance for readability. Read original here.
